Regions Financial Corp Biocryst Pharmaceuticals Inc Transaction History

Regions Financial Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 25, 2022	SELL	$11.56 - $19.76 $177,596 - $303,572	-15,363 Closed	0 $0
Q4 2021 Jan 31, 2022	BUY	$11.18 - $15.46 $171,758 - $237,511	15,363 New	15,363 $213,000
Q2 2019 Jul 19, 2019	SELL	$2.91 - $9.15 $6,984 - $21,960	-2,400 Closed	0 $0
Q4 2018 Jan 28, 2019	BUY	$6.51 - $9.6 $15,624 - $23,040	2,400 New	2,400 $19,000

278

172M

625K

739K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.45B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Regions Financial Corp with notifications on news.